1. Home
  2. SPIR vs MGTX Comparison

SPIR vs MGTX Comparison

Compare SPIR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spire Global Inc.

SPIR

Spire Global Inc.

N/A

Current Price

$9.21

Market Cap

826.5M

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$9.21

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPIR
MGTX
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.5M
881.7M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SPIR
MGTX
Price
$9.21
$9.21
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$18.63
★ $27.75
AVG Volume (30 Days)
455.1K
★ 588.9K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 134.98
33.02
EPS
N/A
★ 0.68
Revenue
★ $110,451,000.00
$81,391,000.00
Revenue This Year
$6.83
$309.55
Revenue Next Year
$30.81
N/A
P/E Ratio
★ N/A
$13.62
Revenue Growth
13.15
★ 144.57
52 Week Low
$6.60
$6.62
52 Week High
$25.93
$15.35

Technical Indicators

Market Signals
Indicator
SPIR
MGTX
Relative Strength Index (RSI) 47.09 43.56
Support Level $8.49 $8.80
Resistance Level $9.94 $10.08
Average True Range (ATR) 0.65 0.53
MACD 0.17 0.08
Stochastic Oscillator 69.10 49.03

Price Performance

Historical Comparison
SPIR
MGTX

About SPIR Spire Global Inc.

Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: